Semaglutide Has emerged as a groundbreaking medication, transforming the landscape of healthcare for those with type 2 diabetes, obesity, and cardiovascular risk factors. Initially developed for diabetes management, semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the natural hormone GLP-1 (glucagon-like peptide-1). This hormone https://nifty20628.ssnblog.com/30335076/semaglutide-revolutionizing-diabetes-management-weight-loss-and-cardiovascular-health